Stay updated on Upadacitinib in RA: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.

Latest updates to the Upadacitinib in RA: Safety & Efficacy Clinical Trial page
- Check4 days agoChange DetectedThe page now displays a 403 Forbidden error screen for the study record, replacing the expected content with a minimal header, navigation, and a Home button.SummaryDifference19%

- Check11 days agoChange DetectedRelated topics were added to the page, including Rheumatoid arthritis and a MedlinePlus Genetics entry. This expansion adds contextual disease terminology and links to genetics information on the study details page.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page’s disease tagging and related resources were reduced by removing the 'Rheumatoid arthritis' topic and the 'MedlinePlus Genetics' related topics, altering the topic taxonomy and associated links.SummaryDifference0.1%

- Check25 days agoChange DetectedThe revision label on the page was updated from v3.6.5 to v3.6.6, indicating a newer version of the page's content or underlying system.SummaryDifference0.0%

- Check32 days agoChange DetectedRheumatoid arthritis was added as a related topic, and a related topics section now references MedlinePlus Genetics. This expands the educational and context links available on the page but does not alter the study details.SummaryDifference0.1%

- Check39 days agoChange DetectedRheumatoid arthritis, the related topics header, and the MedlinePlus Genetics link were removed, eliminating the main condition context and linked resources from the page.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib in RA: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.